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Endoplasmic Reticulum protein-29 (ERp29) is a novel endoplasmic reticulum (ER) 
chaperone protein that plays an important role in the unfolding and guide of secretory 
proteins. In this thesis, the roles of ERp29 in regulating cell migration, apoptosis and 
proliferation were investigated. After knockdown of ERp29, wound healing ability of 
BMSCs was remarkably down-regulated. And the quantitative analysis further 
confirmed the reduction of cell migration. Meanwhile, the expression of Par3 and Par6, 
the Par polarity complex protein, was largely reduced in both mRNA and protein levels 
in ERp29-silencing BMSCs, indicating that ERp29 might directly mediate the Par6-
Cdc42-Par3 pathway therefore regulate the cell migration. Evidence also showed that 
cell apoptosis was highly increased after ERp29 silencing, which suggested that ERp29 
might play an important role in regulation of cell apoptosis in BMSCs. In addition, cell 
proliferation assay demonstrated the reduction of cell proliferation after ERp29 
knockdown, however without statistical significance. 
 
Migration capability and the ability of keeping a balanced number of cells during 
differentiation make BMSCs to be potential therapeutic strategy. The novel role of 
ERp29 in regulating the migration, apoptosis and cell proliferation offers us an 
opportunity to better method to mediate the behavior of BMSCs and make them more 
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1.1 Bone Marrow Stem Cell 
1.1.1 Characteristics of Bone Marrow Stem Cells 
1.1.1.1 Differentiation Capacity 
Bone marrow mesenchymal stem cells (BMSCs) are multipotent stromal cells that are 
isolated from the bone marrow of the femur, hip, rib and sternum. The most significant 
characteristic of BMSCs is their abilities to continuously maintain a balanced number of 
stem cells while being able to differentiate into a variety of cell types.  As they are  
progenitors of lineages of mesenchymal tissues, they have demonstrated their capability 
to differentiate into bone, cartilage, the hematopoiesis-supporting stroma, and 
adipocytes (Bianco et al., 2001). BMSCs also have been proved that they could be 
induced to differentiate exclusively into adipocytic, chondrocytic, or osteocytic lineages 
(Pittenger et al., 1999). What’s more, studies have confirmed that BMSCs are able to 
transdifferentiation into neuron-like cells because of their expression of neural markers 
after migration into brain injury areas (Kopen et al., 1999). And earlier studies have 
verified that BMSCs have the potential to differentiate into endodermal lineages (Tian 
et al., 2010). Although the differentiation capacity of BMSCs is so powerful, there are 
still certain drawbacks. Firstly, the capacity of differentiate of BMSCs have been shown 
to decrease with the age of the donor. And this phenomenon has also been confirmed in 
cell culture with repeated passage. Therefore, this might create a decrease in the number 
of BMSCs or a functional change to the existing BMSCs. Secondly, the 
microenvironment is important in the process of BMSCs differentiation and it is 
difficult to control (Engler et al., 2006). The degree and direction of differentiation vary 
among individuals because of the variation of method and extent of induce. Lastly, there 
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is persistent doubt whether the BMSCs differentiated cells are totally functional. As 





 currents and action potentials, as well as functional neurotransmitter 
receptors (Franco Lambert et al., 2009). 
 
1.1.1.2 Immunomodulatory Effects 
BMSCs have unique immunoregulatory and regenerative properties that make them an 
attractive tool for the cellular treatment of autoimmunity and inflammation (Le Blanc 
and Mougiakakos, 2012).  Some scientists have observed that BMSCs can suppress T 
cell proliferation by inhibiting interferon (IFN)-γ and tumor necrosis factor (TNF)-α and 
increasing interleukin (IL)-10 production (Caplan, 2007). BMSCs also have been 
proved to inhibit the proliferation and cytotoxicity of nature killer (NK) cells via 
prostaglandin E2 (PGE2) and to maneuver the mature dendritic cells (DCs) and 
monocytes to an immature DC state which cause them more liable to be degradation by 
NK cells (Uccelli et al., 2008). In addition, BMSCs have the ability to suppress of B cell 
proliferation by blocking the G0/G1 phases of the cell cycle, and reducing the 






Figure 1.1 Diagram of Immunomodulatory Effect of BMSCs on Immune Cells. 
Immunomodulatory effects of BMSCs include inhibition of T cell proliferation, 
induction of regulatory T cells (Treg cells), steering monocytes and mature DC cells to 
an immature DC state, inhibition of B cell proliferation and terminal differentiation, and 
suppression of NK cell function. Figure was modified from Yi and Song, 2012. 
 
 
1.1.1.3 Migration Ability 
Another important characteristic of BMSCs is their ability of migration, which is a 
crucial step for BMSCs to involve in the process of tissue healing. Some scientists have 
pointed out that BMSCs appeared to preferentially home to site of inflammation when 
injected to the peripheral blood (Chapel et al., 2003; Ortiz et al., 2003). This homing 
phenomenon also has been verified in stroke therapy (Hess and Allan, 2011). The 
mechanism of regulating the migration of BMSCs is involved with the participation of 
numerous of chemoattractants and receptors, signaling pathways and endogenous 
elongation factors (EFs) (Li and Jiang, 2011). Several chemokines such as stromal-
derived factor 1 (SDF-1), lysophosphatidic acid (LPA) have been showed their ability to 
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induce, mobilize and home BMSCs migration via specific C-X-C chemokine receptor 
type 4 (CXCR4) and G protein-coupled LPA1 receptor expressed on the surface of 
BMSCs (Li et al., 2007; Jeon et al., 2006). In inflammatory microenvironment, 
migration behavior of BMSCs is proved to be regulated by some of the pro-
inflammatory cytokines like TNF-α, and macrophage migration inhibitory factor (MIF) 
(Zhang et al., 2010; Fischer-Valuck et al., 2010). Studies have also showed that 
extracellular high mobility group box 1 (HMGB1) and several growth factors such as 
hepatocyte growth factor (HGF), epidermal growth factor (EGF), and platelet-derived 
growth factor (PDGF) could act as chemoattractants for BMSCs migration (Meng et al., 
2008; Ponte et al., 2007; Forte et al., 2006). In endogenous electric fields, EFs could 
guide the orientation of BMSCs perpendicular to the EF direction (Tandon et al., 2009). 
These extracellular signals mentioned above are transduced into the cells through 
intracellular signaling pathways, such as phosphoinositide 3-kinase (PI3K)/Akt 





Figure 1.2 Regulatory factors of migration of BMSCs. External signals, including 
chemokines and endogenous electric fields, are transduced through membrane receptors 
to downstream signaling pathways to regulate migration of BMSCs. Figure was 
modified from Li and Jiang, 2011.  
 
1.1.2 Bone Marrow Stem Cell Therapy 
In summary, BMSCs have strong capability to differentiate into different types of cell 
lineages, they have unique immunoregulatory and regenerative properties, and their 
ability of migration is an essential step in the process of tissue healing. In addition, they 
are simply isolated, low immunogenic, and lack of ethical controversy. All these 
important characteristics of BMSCs make them excellent candidates to guide intrinsic 
repair and improve disease prognosis since they were firstly isolated from fibrolast-like, 
plastic-adherent cells in whole bone marrow cells culture in 1970s (Friedenstein et al., 
1974).  
 
One of the main aspects of clinical application of BMSCs has carried out on tissue 
regeneration for cartilage, bone, muscle, tendon and neuronal cells. Some studies have 
reported that transplantation of BMSCs effectively reduced lesion volume and improved 
functional outcomes in an animal ischemic brain injury model (van Velthoven et al., 
2012). BMSCs are also capable to be applied to gene therapy as cell vehicles, enhancing 
the efficiency of hematopoietic stem cell engraftment, and treating immune diseases 
such as graft-versus-host disease (GVHD), rheumatoid arthritis, experimental 
autoimmune encephalomyelitis, sepsis, acute pancreatitis and multiple sclerosis (Yi and 




1.2 Cell Migration 
Cell migration is a fundamental multistep process in the development and maintenance 
of multicellular organisms. As early as implantation, the orchestrated movement of cells 
in specific directions to restricted sites is a prominent factor in the process of embryonic 
development, tissue healing and immune surveillance. The consequences could be fatal 
when mistakes have happened during any step of the process. Some of important 
pathological processes include mental retardation, vascular disease, chronic 
inflammatory disease, and tumor formation and metastasis. Therefore, understandings 
of the mechanism in manipulating cell migration could hold the promise of novel 
therapeutic strategies for treatment of diseases, such as suppression of invasive tumor 
cells or promotion of specific migration of stem cells. The processes of cells migration, 
which involve in the extensive intracellular signaling network, have been revealed, 
including establishment of polar structures, regulation of dynamic processes of actin and 
microtubule polymerization, and regulation of spatial and temporal signal transduction 
(Ridley et al., 2003).  
 
1.2.1 Polarity in Migrating Cells 
A spatial asymmetry in the shape, structure, and function, is a fundamental step for 
migrating cells, which could allow them to turn intracellular generated forces into net 
cell body translocation (Lauffenburger and Horwitz, 1996).  One demonstration of this 
spatial asymmetry is cell polarity: a clear distinction between cell front and rear, which 
ensure cells to move towards a particular direction instead of spread out towards 
everywhere. Although great efforts have been made to study the molecular mechanism 
of establishment and maintenance cell polarity, little has been revealed. Cell division 
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control protein 42 (Cdc42) and Par polarity complex protein, including Par3, Par6, and 
atypical protein kinase C (aPKC), may play crucial roles in the generation and 
controlling direction of polarity in eukaryotic organisms. In the early stage of polarity, 
aPKC bounding with Par6 restricts kinase activity of aPKC which is bound to the 
Scribble and Crumbs polarity complex protein, such as Crumbs (Crb) and Lethal giant 
larvae (Lgl). After binding to activated Cdc42-GTP, the Par6-associated aPKC kniase 
activity is promoted, which lead to the recruitment of Par3 and release of the Scribble 
and Crumbs polarity complex. And this interaction subsequently may result in 
localizing the microtubule-organizing center (MTOC) and Golgi apparatus in front of 
the nucleus, oriented toward the leading edge (Ridley et al., 2003).  Several additional 
proteins, such as Serine/threonine-protein kinase 1 (PAK1), PI3Ks and Phosphatase and 
tensin homolog (PTEN), are involved in the process of polarity by upregulating the 
Cdc42 activity via interaction with Cdc42 and the response of shallow chemoattractant 
gradients.  
 
1.2.2 Formation of Protrusion and Adhesion  
The migration process can be described as a cyclic process, which initiates with the 
formation of a protrusion. These protrusions are driven by actin filaments. One of the 
regulators of actin polymerization is the actin-related protein (Arp2/3) complex. The 
complex, mediated by the WASP/WAVE proteins, attaches to the side of existing actin 
filaments and induces growth of a new branch of actin filament at a unique 70 degree 
angle from the preexisting actin filament. Proteins, such as profiling and ADF/cofilin, 
are also act as regulators in mediating actin polymerization by controling the availability 
of activated actin monomers, debranching and depolymerizing proteins and capping and 
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severing proteins (Ridley et al., 2003). Protrusions are then stabilized by adhering to the 
surroundings. Integrins play an essential role in this process.  They regulate the 
adhesions to the extracellular matrix (ECM) or other cells by interacting with actin 
filaments in migrating cells. Integrins can also act as signal transducer in the “inside-out 
signaling” model. The activation of integrins is caused by talin binding through PKC-, 
Rap1-, and PI3K-mediated pathways (Ridley et al., 2003).  
 
1.2.3 Rear Retraction 
At the cell rear, adhesions are released as the rear retracts. Then theses components can 
be utilized for assembling new adhesions towards the front of the cell, or alternatively, 
moving to the cell edge. This process is regulated by transport of components by 





Figure 1.3 Steps in cell migration. A. Cell Polarization: Cdc42 and Par polarity 
complex proteins are involved in the generation of polarity and result in localizing the 
MTOC and Golgi apparatus in front of the nucleus, oriented toward the leading edge. 
PAK1, PI3Ks and PTEN are implicated in polarity by upregulating the Cdc42 activity 
and the response of shallow chemoattractant gradients. B. Protrusion and adhesion 
formation: WASP/WAVE proteins regulate the formation of actin branches on existing 
actin filaments through the Arp2/3 complex. Actin polymerization is also regulated by 
proteins such as profilin and ADF/cofilin. Protrusions are stabilized by the formation of 
adhesions, which is mediated by integrins. C. Rear retraction: at the cell rear, 
adhesions disassemble as the rear retracts, which is mediated by signaling pathways, 
such as Src/FAK/ERK pathway, and the delivery of components by microtubules. 
Figure was modified from Ridley et al., 2003. 
 
1.3 Apoptosis 
One important step in BMSCs therapy involves ensuring the survival of transplanted 
cells in the microenvironment in injury site, which is largely dependent on the balance 
between cell apoptosis and cell proliferation. Apoptosis, programmed cell death, plays 
an essential role in the process of boy health development and maintenance by 
eliminating the old, unnecessary, and unhealthy cells in the predictable place at 
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predictable times without releasing harmful substances into the microenvironment in 
multicellular organisms. Keeping the activity of apoptosis in a moderate level is crucial 
in regulating the cell numbers and defending the threat appeared in the 
microenvironment by eliciting unwanted and potentially harmful cells, such as tumor 
cells, virus infected cells and self-reactive lymphocytes (Estaquier et al., 2012). 
Inappropriate activation of apoptosis, which kills too many healthy cells, may cause 
serious consequences, such as acquired immunodeficiency syndrome (AIDS), 
neurodegenerative diseases and ischemic stokes. While, deactivation of apoptosis, 
which lead to persisting of unwanted cells, in undesired places at undesired times could 
also attribute to some autoimmune diseases, cancer, leukemia and so on. The apoptosis 
process is associated with characteristic morphological and biochemical changes, such 
as membrane blebbing, cell shrinkage, chromatin condensation, DNA cleavage and 
fragmentation of the cell into membrane-bound apoptotic bodies whose surface 
expresses potent triggers for phagocytosis (Estaquier et al., 2012). Apoptosis is a 
complicated multi-step process, which is activated by variety of stimuli originated either 
extracellularly or intracellularly and mediated by a diversity of regulators, including 
caspases, caspase activators, B-cell lymphoma-2 (Bcl-2) family proteins and Inhibitor 
of Apoptosis Proteins (IAPs).  
 
 
Figure 1.4 Morphological Changes in the Apoptosis Process. The apoptosis process 
is associated with characteristic morphological changes, such as cell shrinkage, 
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chromatin condensation, membrane blebbing, DNA cleavage and fragmentation into 
apoptotic bodies whose surface expresses potent triggers for phagocytosis. Figure was 
modified from Kerr et al., 1994. 
 
 1.3.1 The Role of Caspase Proteases in Apoptosis 
Apoptosis is executed through activation of Caspases, a type of cysteine proteases 
contains the consensus sequence QACXG in the active site, by cleaving two different 
types of substrates of the proteases (Munoz-Pinedo, 2012; Momoi, 2004). Apotosis 
caspases can be divided into two groups according to the sequence homology and their 
characters in the proteolytic cascade: initiator caspases (caspase-8/9) with a long 
prodomain carrying a protein/protein interaction motif (Caspase Activation and 
Recruitment Domain (CARD) or Death Effector Domain (DED)) and executioner 
caspases (caspase-3/7) with a short prodomain (Munoz-Pinedo, 2012). Caspases are 
normally present as inactive status until the extrinsic or intrinsic inducer triggers the 
cleavage of caspase activators (also called pro-caspases). And then, the initiator caspase 
is activated by oligomerization and cleavage, which subsequently activates the effector 
caspases via cleavage of their substrates and results in an irreversible proteolytic 
cascade until the cell is killed. The cleaved substrates can be classified into two 
different subsets. The first group is responsible to maintain the cellular structures. 
Cleavage of these substrates leads to characteristic morphological changes associated 
with apoptosis process. Another group of substrates are involved in the “life support” 
functions such as transcription and translation, metabolism, growth promoting signaling 





1.3.2 The Role of Bcl-2 Family Proteins in Apoptosis  
1.3.2.1 The Classification of Bcl-2 Family Proteins  
The Bcl-2 family proteins play an important role in controlling the apoptosis process at 
early stages by regulating the permeability of the mitochondrial membranes and the 
releasing of mitochondrial cytochrome c and other mitochondrial intermembrane space 
proteins into cytosol. The family members share homologies restricted to 1 to 4 domains 
(BH1-4) (Estaquier et al., 2012). Proteins with four BH domains, such as Bcl-2, Bcl-xL, 
Bcl-W and Mcl-1, are anti-apoptotic, other members of this family are pro-apoptotic 
(Chipuk et al., 2010). And the pro-apoptotic proteins can be further divided into 
multidomain proapoptotic proteins and BH3 only proteins (BOPs). The multidomain 
pro-apoptotic proteins, including Bax, Bak and Bok, contain a BH1-3 domains 
homology while BOPs are essentially restricted to the BH3 domain (Chipuk et al., 
2010).  
 
1.3.2.2 The role of Bcl-2 Family Proteins  
Anti-apoptotic Bcl-2 family members inhibit apoptosis process by  differentially 
binding to BOPs and preventing BOP-induced oligomerization of the pro-apoptotic 
proteins Bax and/or Bak in mitochondrial outer membranes, which would otherwise 
lead to the efflux of cytochrome c and other mitochondrial intermembrane space 
proteins (Taylor et al., 2008). Members of this group, such as Bcl-2 and Bcl-xL, are 
normally overexpressed in human cancer cells and therefore prevent them from 
apoptosis. The multidomain pro-apoptotic Bcl-2 family members, Bax and Bak, are 
responsible for the mitochondrial apoptotic permeability by forming pores in the 
mitochondrial membranes and promoting the release of cytochrome c (Munoz-Pinedo, 
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2012). There are eight numbers of BOPs, which can be categorized into two groups. 
The first group members containing BID, BIM and PUMA can interact with all 
multidomain anti-apoptotic proteins. Another group of proteins including BIK, BMF, 
BAD, NOXA, HRK only interact with certain type of anti-apoptotic proteins. BID, BIM 
and PUMA has shown their ability of directly activating Bax or Bak and inducing their 
change of conformation and mitochondrial integration by a “kiss and run” mechanism 
(Youle and Strasser, 2008; Chipuk et al., 2010; Kim et al., 2009). The rest of BOPs are 
considered as inhibitors of anti-apoptotic proteins. These proteins are specifically 
induced by particular inducers. For example, PUMA and NOXA are activated in a p53-
dependent manner under stress of DNA damage while BAD specifically response to 






Figure 1.5 The Bcl-2 Family Members. The Bcl-2 family proteins play an important 
role in controlling the apoptosis process at early stages by regulating mitochondrial 
cytochrome c relaese. The family members share homologies restricted to 1 to 4 
domains (BH1-4). Proteins with four BH domains are anti-apoptotic; other members of 
this family are pro-apoptotic, which can be further divided into multidomain 
proapoptotic proteins, containing a BH1-3 domains homology and BH3 only proteins 
(BOPs ) which are essentially restricted to the BH3 domain. The figure was reproduced 
from Taylor et al., 2008. 
 
1.3.3 Caspases Activation Pathways 
Caspases can be activated by three pathways: the extrinsic pathway, the intrinsic 
pathways, and Granzyme B pathway. In the extrinsic pathway, the extracellular death 
ligands, such as Fas Ligand (FasL) or TNF-α, bind to and activate transmembrane death 
receptors, which therefore recruit the adaptor proteins, such as the Fas-associated death 
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domain protein (FADD). Subsequently, caspase-8 is recruited, aggregated and activated 
via interaction with Death Effector Domain (DED). Actived caspase-8 then cleaves and 
activates caspase-3 and -7, triggering the irreversible proteolytic cascade which finally 
leads to cell death. Under certain circumstances, extrinsic death signals can crosstalk 
with the intrinsic pathway through caspase-8-mediated proteolysis of the BID, while 
truncated BID (tBID) can promote mitochondrial cytochrome c release and assembly of 
the apoptosome (apoptotic protease-activating factor-1 (APAF1) and caspase-
9 homodimers) (Taylor et al., 2008).  
 
In the intrinsic pathway, a variety of stimuli, such as DNA damage, activate one or more 
members of the BOPs. Then the activated BOPs inhibit anti-apoptotic proteins and 
promote the assembly of Bak–Bax oligomers within mitochondrial outer membranes 
(Taylor et al., 2008). These Bak-Bax oligomers form holes in the outer mitochondrial 
membranes to increase the mitochondrial apoptotic permeability and promote the 
release of cytochrome c and other intermembrane space proteins into the cytosol. On 
release from mitochondria, cytochrome c can seed apoptosome assembly (Taylor et al., 
2008). Subsequently, caspase-9 is activated therefore triggers the activation of caspases 
in the proteolytic cascade.  
 
The caspase activation can also be induced through the granzyme B-dependent pathway 
by delivery of granzyme into the target cell. Granzymes are mainly presented in 
cytotoxic T lymphocytes (CTL) or natural killer (NK) cells. Perforin, a pore-forming 
protein also released from CTL and NK, can oligomerizes in the membranes of target 
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cells to permit entry of the granzymes (Taylor et al., 2008). Then Granzyme B activates 
BID and caspase-3 and -7 to trigger the apoptosis process.  
 
 
Figure 1.5 Caspase Activation Pathways. 1. The extrinsic pathway: the extracellular 
death ligands activate transmembrane death receptors and then recruit the adaptor 
proteins. Subsequently, caspase-8 is activated, which then then activates caspase-3 and -
7, triggering the irreversible proteolytic cascade. Under certain circumstances, extrinsic 
death signals can crosstalk with the intrinsic pathway through caspase-8-mediated 
proteolysis of the BID. 2. The intrinsic pathway: extracellular or intracellular stimuli 
activate one or more members of the BOPs, which then inhibit anti-apoptotic proteins 
and promote the assembly of Bak–Bax oligomers within mitochondrial outer 
membranes. These oligomers promote the release of cytochrome c which can seed 
apoptosome assembly and activate caspase-9. 3. The granzyme B-dependent pathway: 
caspases are activated by delivery of granzyme into the target cell from CTL or NK 
cells. Perforin, released from CTL and NK, can oligomerizes in the membranes of target 
cells to permit entry of the granzymes. Then Granzyme B activates BID and caspase-3 
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and -7 to trigger the apoptosis process. The figure was reproduced from Taylor et al., 
2008. 
 
1.4 Endoplasmic reticulum resident protein 29  
The endoplasmic reticulum resident protein 29 (ERp29) is a reticuloplasmin which 
resides in the lumen of the endoplasmic reticulum (ER) (Ferrari et al., 1998). Protein 
sequence analysis demonstrated that ERp29 contains an ER-targeting hydrophobic N-
terminal leader sequence and a C-terminal tetra-peptide, Lys-Glu-Glu-Leu (KEEL), 
which is a conserved variant of the Lys-Asp-Glu-Leu (KDEL) retrieval signal of soluble 
ER luminal proteins (Munro and Pelham, 1987).It was first cloned from rat enamel cells 
and later from human liver tissues (Demmer et al., 1997; Hubbard and McHugh, 2000). 
ERp29 is extremely conserved among mammals, with homolog windbeutel found in 
organism as primitive as Drosophila (Hubbard et al., 2000). It is also has been proven 
that ERp29 is widely expressed among fetal and adult mammalian cells and tissues with 
high level of expression, such as adrenal, mammary, enamel, prostate, thyroid, and liver 
(Mkrtchian et al., 1998b; Hubbard and McHugh, 2000; Liepinsh et al., 2001; Sargsyan 
et al., 2002b). Additionally, the most significant characteristics of its promoter are 
including GC rich, absence of TATA box, and presence on multiple transcription start-
sites (Sargsyan et al., 2002a). All the observations indicate that ERp29 is a 
constitutively expressed housekeeping gene with a function of general importance 
(Sargsyan et al., 2002a). 
 
Unlike other luminal ER proteins, ERp29 belongs to a group of redox-inactive ER 
proteins based on two reasons. Firstly, ERp29 lacks the post-translational modifications, 
ATP-dependent or calcium-binding properties and some redox enzyme properties, such 
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as disulfide-editing (Ferrari et al., 1998; Mkrtchian and Sandalova, 2006). And 
structurally, the N-terminal domain of ERp29 contains a thioredoxin fold which is 
similar to that of protein disulfide isomerase (PDI) but lack an active motif of double-
cysterine motif essential for disulfide-bond formation, while C-terminal domain holds a 
helix fold which is absent in human PDI (Liepinsh et al., 2001; Barak et al., 2009). 
Based on the theses characteristics, ERp29 has to be complemented by PDI-like redox-
active chaperones which facilitate protein unfolding and secretion (Mkrtchian and 
Sandalova, 2006). 
 
1.4.1 Structure and Distribution 
The human ERp29 gene is located at chromosome 12q24.13 and contains three small 
exons separated by one small and one large introns (Sargsyan et al., 2002a). ERp29 
gene encodes a 25.6 kDa protein of 261amino acid residues (Demmer et al., 1997). 
Secondary structure analysis reveals that the strong hydrophobic N-terminal of ERp29 
containing ER-targeting peptide will be cleaved in mature protein (Mkrtchian et al., 
1998b). The C-terminal KEEL motif located at C-terminal is a variant of ER-retention 
motif which can be recognized by specific receptor that continually retrieves the protein 
from later compartment of secretory pathway and returns them to the ER (Mkrtchian et 
al., 1998b). The tertiary structure of ERp29 protein is characterized by an N-terminal 
domain and a C-terminal domain connected with a flexible loop (residue 149-159), 
which is highly conserved among mammals (Barak et al., 2009). The N-terminal 
contains a typical α/β thioredoxin fold (Barak et al., 2009). The C-terminal has a novel 
helical fold, which is highly similar to Windbeutel (Liepinsh et al., 2001; Lippert et al., 
2007; Barak et al., 2009). Further mutagenesis analysis indicates that residues Gly37, 
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Leu39, Asp42, Lys48 and Lys 52 are essential to the dimerization of ERp29 (Rainey-
Barger et al., 2007; Lippert et al., 2007). The C-terminal domain contains a tetra-
peptide, KEEL, and five helices (helix 5-9), among which helices 7, 8 and 9 form a 
hydrophilic patch (Zhang and Richardson, 2011). And several conserved residues in 
helix 8 (Glu222, Arg225, Lys228 and Leu229) and helix 9 (Leu242) have been 
identified as the substrate-binding site (Lippert et al., 2007; Barak et al., 2009). The 
Cys125 and Cys157 residues are crucial to the stability of the C-terminal domain and 
the Cys125 also plays an important role in the hydrophobicity of interdomain linker 
(Hermann et al., 2005; Baryshev et al., 2006). 
 
 
Figure 1.6 Secondary structure of ERp29. ERp29 consists of 261 residues which are 
composed of: (1) a signal peptide (residues 1–32) targeting it to the endoplasmic 
reticulum; (2) an N-terminal domain (NTD, residues 33–153) containing a typical α/β 
thioredoxin fold; (3) a C-terminal domain (CTD, residues 154–257) consisting of 5 
helices essential for substrate-binding; and (4) a tetra-peptide, KEEL. Several key 
residues are responsible for dimerization and substrate binding. Figure was reproduced 
from Zhang and Richardson, 2011.  
 
Size exclusion chromatography, cross-linking and dynamic light scattering studies 
identify the oligomerization of ERp29, which is essential for its diverse functions 
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(Mkrtchian et al., 1998a; Ferrari et al., 1998). Studies have shown that lose of the ability 
of efficient dimerization, caused by ERp29 mutation, is incapable to regulate 
polyomavirus infection and thyroglobulin (Tg) secretion (Rainey-Barger et al., 2007). 
The N-terminal and residues Gly37, Leu39, Asp42, Lys48 and Lys 52 regulate and are 
essential for the dimerization of ERp29 (Liepinsh et al., 2001; Lippert et al., 2007; 
Rainey-Barger et al., 2007). 
 
As a luminal protein, ERp29 has been proven to localize in the luminal part of ER by 
biochemical and morphological analysis, which is consistent with the presence of KEEL 
motif in its C-terminal (Mkrtchian et al., 1998b). However, this localization is not 
exclusive, studies has revealed that ERp29, the production of lactation, presents in 
cytoplamic lipid droplets (CLD) (Wu et al., 2000).What’s more, ERp29 has been found 
to be co-secreted with its substrate Tg (Sargsyan et al., 2002b). Additionally, the 
existence of ERp29 has been identified in nuclei in tumor and control cells by tissue 
staining (Cheretis et al., 2006). 
 
1.4.2 Expression and Activation 
ERp29 is highly expressed in secretory tissues, such as adrenal, mammary, thyroid and 
salivary glands, as well as the prostate, pancreas and liver (Mkrtchian and Sandalova, 
2006). In addition, the high level of ERp29 expression has been identified in epithelial 
cancers (Shnyder et al., 2008). Immunohistochemistry studies have revealed the 
ubiquitous expression of ERp29 in neuronal and non-neuronal cells in diverse locations 
especially the cerebellum of the rat brain (MacLeod et al., 2004). The expression of 
ERp29 can be activated under several conditions. Firstly, the ERp29 expression is 
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remarkably increased when cells are undergoing the cellular stress, such as radiation, 
homocysteine, and dopamine (Zhang et al., 2008; Hung et al., 2009; Dukes et al., 2008). 
As an ER protein, ERp29 is expressed when cells are exposed to unfolded protein 
response (ER stress) (Zhang and Richardson, 2011). However, unlike PDI and Binding 
Protein (BiP), the transcription of ERp29 cannot be directly mediated by ER stress 
because of the lack of ER-stress response element (CCACG) in the promoter region of 
ERp29 gene (Sargsyan et al., 2002a; Ferrari et al., 1998). ERp29 promoter analysis has 
revealed the binding sites of numerous transcription factors, such as GATA-1, Sp1, E2F 
and CRE-BP1 (Sargsyan et al., 2002a). And the basal expression is mostly determined 
by the combined activities of these transcription factors (Sargsyan et al., 2002a). All the 
evidences suggest that upregulation of ERp29 under ER stress is possibly induced by 
these transcription factors and other regulatory elements.  
 
1.4.3 Functions 
1.4.3.1 Protein Secretion and Calcium Regulation 
In eukaryotic cells, reticuloplasmins, such as PDI, BiP, calreticulin, and endoplasmin, 
are responsible to production of secretory proteins and calcium regulation (Brodsky and 
McCracken, 1997; Dorner et al., 1990). These proteins have various tasks, such as 
protein-folding assistants, disulphide isomerase, and calcium buffers. As a 
reticuloplasmin, ERp29 is a possible protein-folding assistant since it lacks calcium 
binding properties and a double-cysterine motif which is essential for disulfide-bond 
formation. This role of ERp29 can be verified by several aspects. Firstly, ERp29 is 
highly expressed in secretory tissues (Mkrtchian and Sandalova, 2006). And the 
expression of ERp29 is remarkably increased under ER stress condition (Mkrtchian et 
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al., 1998b). Additionally, the cellular expression profile of ERp29 is similar to that of 
PDI during the proliferation and secretary stages of lactation, while its location is the 
same as that of BiP and other ER chaperones in the rough ER (Shnyder et al., 2008; 
Mkrtchian et al., 1998b). Studies have identified that ERp29 is involved in the 
production and/or secretion of numerous proteins, such as thyroglobulin, connexin34, 
and soluble milk proteins (Baryshev et al., 2006; Das et al., 2009; Mkrtchian and 
Sandalova, 2006). Furthermore, ERp29 has been reported to regulate the ER membrane 
penetration during the process of Polyomavirus infection, sperm maturation (Magnuson 
et al., 2005; Ying et al., 2010).  
 
1.4.3.2 ER Stress Signaling 
As a ER protein, ERp29 is also implicated in the ER-stress response which initiates an 
unfolded protein response (UPS) characterized by transcriptional induction of genes that 
enhance protein folding capacity and general translational attenuation to reduce protein 
load in the ER (Mkrtchian et al., 1998b). Generally, under ER stress, X-box binding 
protein-1 (XBP1) is spliced by phosphorylated inositol-requiring 1α (IRE1α), followed 
by the activation of the unfolded protein response-target genes and stimulation of ER-
dependent apoptosis by triggering the JUN N-terminal kinase (JUK)-mediated signaling 
cascade (Zhang and Richardson, 2011). Meanwhile, double-stranded RNA-activated 
protein kinase-like ER kinase (PERK) inactivates eukaryotic translation initiation factor 
2α (Eif2α) via phosphroylation, and then leading to inhibition of cyclin D1 and/or 
increased expression of the pro-apoptotic transcription factor, GADD153/CHOP by 
activating transcription factor 4 (ATF4)  (Wang et al., 2010; Zhang and Richardson, 
2011). ERp29 is considered to be regulated via XBP1/IRE1 pathway under ER stress 
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because of the lack of ER stress response properties and the fact that XBP1 functionally 
binds to DNA element instead of ER element (Mkrtchian et al., 1998b). Studies have 
indicated that XBP1 and p38 down-regulates the ERp29 expression, contrarily 
overexpression of ERp29 activates XBP1 (Bambang et al., 2009a; Zhang and Putti, 
2010). 
 
1.4.3.3 Mesenchymal-Epithelial Transition and Development in Cancer 
Both epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition 
(MET) are essential in the cancer process. The EMT plays a significantly role in tumor 
progression via increasing invasion, metastatic dissemination and therapeutic resistance 
(Zhang and Richardson, 2011). While the further formation of distant metastases is 
largely relied on MET (Chaffer et al., 2007). ERp29 has been implicated in regulation 
of MET in mesenchymal-like MDA-MB-231 breast cancer cells which results in the 
loss of mesenchymal properties and cell marker, vimentin, and the gain of epithelial 
characteristics and cell marker, E-cadherin (Bambang et al., 2009b). Mechanistic 
studies reveal the role of ERp29 in the MET. ERp29 inhibits the transcription factors, 
such as Twist, Ets-1 and Slug, and their upstream regulator, the extracellular signal-
regulated kinase (ERK), therefore up-regulates Ecadherin, which is an indication of 
MET (Bambang et al., 2009b; Zhang and Richardson, 2011).  
 
Great efforts have been devoted to reveal the role of ERp29 in the development of 
cancer. However, the role of ERp29 in tumorigenesis has not been not fully clarified 
because of the conflicting results. As an oncogene, knockdown of ERp29 in non-
invasive MCF-7 breast cancer cells results in reduction of tumor formation (Mkrtchian 
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et al., 2008). As a tumor suppressor, ERp29 inhibits tumor formation in mice bearing 
ERp29-transfected MDA-MB-231 xenografts (Bambang et al., 2009b). In addition, 
over-expression of ERp29 indirectly leads to transcriptional activation of genes with 
tumor suppressive function, such as E-cadherin and spleen tyrosine kinase (Bambang et 
al., 2009b; Zhang and Richardson, 2011). 
 
1.5 Scope of Study  
The ubiquitous and highly conserved expression of ERp29 indicates its crucial role in 
mediating basic cell functions, which makes it to be a possible clinical-pathological 
parameter in BMSC therapy. However, great efforts are still needed to unravel the 
expression and the possible character of ERp29 in regulating the basic activities of 
BMSCs. Thus, the aim of my study is to preliminarily clarify the expression and basic 
functions of ERp29 in mediating cell migration, apoptosis and proliferation in BMSCs, 
which therefore could lead to the enhancing the efficacy of BMSC therapy by 
manipulating expression of ERp29. To achieve this aim, several steps could be carried 
out:  
i. To observe the expression of ERp29 in BMSCs. Silencing of ERp29 in BMSCs 
will be conducted when the expression is statistically significant. 
ii. To preliminarily clarify the functions of ERp29 in mediating the activities of 
BMSCs. The migration (wound healing assay and transwell assay), apoptosis 
(TUNEL assay) and proliferation (cell proliferation assay) of BMSCs will be 
evaluated before and after the ERp29 Silencing. 
iii. To further study the role of ERp29 in the process of migration, the expression of 
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2. Materials and methods 
2.1 Isolation of Rat Bone Marrow Stem Cells 
The Bone Marrow Stem Cells (BMSCs), a type of mesenchymal stem cells extracted 
from the femurs and tibias of adult rats, were obtained from DSO. Their capabilities in 
differentiation into numerous cell types and secreting immunomodulatory factors have 
been demonstrated (Lu et al., 2006; Lu et al., 2005a; Lu et al., 2005b).  
 
Sprague-Dawley rats were euthanasized in a carbon dioxide chamber. BMSCs were 
isolated according to the protocol written by Soleimani and Nadri (Soleimani and Nadri, 
2009). Firstly, BMSCs were collected from the tibia and femoral bone marrow of 
Sprague-Dawley rats by inserting a 26-gauge syringe at bone cavity, followed by 
washing with Dulbecco's Modified Eagle’s Medium (DMEM) (Caisson Labs, U.S.A). 
Then the cell suspension was filtered through a 70mm filter mesh to remove bone 
spicules and muscle clumps. After that, BMSCs were cultured at a density of 25x10
6
 
cells/ml in complete medium (DMEM with 15% Fetal Bovine Serum (FBS) (Hyclone, 
Germany)) in 95 mm culture dishes and incubated for 3 hours at 37°C and 5% CO2 in a 
humidified incubator. Then non-adherent cells were removed by changing the culture 
medium with fresh complete medium. The culture medium was changed with 1.5ml 
fresh complete medium every 8 hours for up to 72 hours in culture. The adherent cells 
(passage 0) were then washed with 1x phosphate buffered saline (PBS). After washing, 
the culture medium was changed with fresh complete medium every 3 days. After 2 
weeks of initiating culture, the BMSCs were washed with 1x PBS and were lifted by 
0.25% trypsin/ 1 mM ethylenediaminetetraacetic acid for 2 min at room temperature. 





 flask. The culture medium was changed with complete medium every 3 
days. The BMSCs usually reached confluence in 7 days. Then BMSCs were 
characterised using Mesenchymal Stem Cell Characterization Kit (Millipore, USA). All 
experimental procedures are approved by IACUC.  
 
2.2 Maintenance of cell culture 
Rat BMSCs were cultured in DMEM, supplemented with 10% FBS and maintained at 
37
o
C and 5% CO2 in a humidified incubator. Cells were consistently sub-cultured twice 
a week and maintained in 75 cm
2
 culture flasks (Cellstar, U.S.A). 
 
2.3 Cryopreservation of cells  
Extra BMSCs were cryopreserved in liquid nitrogen to guarantee the experimental 
usage. Trypsinized cells were centrifuged at 125 g for 5 min at 4°C.After centrifugation, 
the cell pellet was resuspended with DMEM containing 20% FBS and 10% DMSO. 
Then ampules (Nagle Nunc, Roskilde, Denmark) containing 5 x 10
5
 cells were 
transferred to 5100 Cryo 1°C (Nagle Nunc) freezing container and stored overnight at -
70°C, The next day, the ampules were cryopreserved in liquid nitrogen for long term 
storage. 
 
2.4 Silencing of ERp29 Gene 
To study the effect of ERp29 knockdown on rat BMSCs, ERp29 siRNA and negative 
control siRNA (Dharmacon) were used. Rat BMSCs were seeded into 6 well culture 
plates at concentration of 0.3x10
6
 cells/ well. After incubated in 37
o
C and 5% CO2 in a 
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humidified incubator for 24 hrs, transfection was carried out with 20μΜ of siRNA, 
3.5μΜ of Dharmafect 1. Both siRNA and Dharmafect 1 (Dharmacon) were first diluted 
separately in serum free DMEM and incubated for 5 mins at room temperature, then 
were mixed together and incubated for 20 mins at room temperature, followed by 
blended with antibiotics free DMEM supplemented with 10% FBS to reach a final 
siRNA concentration of 25nM. Subsequently, the mixture was added into each well.  
 
A complete medium change was carried out 24 hrs after transfection. BMSCs were then 
incubated at 37
o
C and 5% CO2 in a humidified incubator for 48 hrs (for RNA analysis) 
or 72 hrs (for protein analysis). 
 
Table 2.1 Sequences of siRNA used in ERp29 Silencing 










2.5 Cell Proliferation 
To observe the changes of cell proliferation rate of BMSCs after ERp29 knockdown, 
CellTiter 96
® 
Aqueous One Solution Cell Proliferation Assay (Promega, Germany) was 
used. Rat BMSCs were seeded in triplicate into 96 well culture plates at concentration 
of 1x10
3
 cells per well and then incubated for 4 days at 37
o
C and 5% CO2 in a 
humidified incubator. At each 24 hrs interval, 20μl of CellTiter 96® Aqueous One 
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Solution Reagent was added into each well. And then incubated for 1 hr at 37
o
C and 5% 
CO2 in a humidified incubator, the absorbance at 490 nm was measured by Genios 
multiplate reader (Tecan). After 4 days’ measurement, a relative growth rate was 
conducted. 
 
2.6 Cell Migration 
2.6.1 Wound Healing Assay 
The wound healing assay is a common used simple method to study directional cell 
migration and cell interactions. To begin with, Rat BMSCs were seeded in 6 well 
culture plates until 90-95% confluence. After serum-starved for 24 hrs, BMSCs were 
carefully wounded by using a sterilized yellow pipette tip under an angle of around 30 
degrees to keep the scratch width limited. After removed the detached cells and changed 
the medium to DMEM supplemented with 10% FBS, the BMSCs were photographed 
immediately (t = 0) and after being culture at 37
o
C and 5% CO2 in a humidified 
incubator for 12 hrs (before ERp29 knockdown) or 15 hrs (after ERP29 knockdown) in 
10x objective by using Nikon Digital Sight-L2 (Nikon). 
 
2.6.2 Transwell Assay 
Quantitative cell migration assays were performed by using Cytoselect
TM
 24-Well Cell 
Migration Assay (Cell Biolabs, U.S.A.). After serum-starved for 24hrs, rat BMSCs were 
harvested and prepared into a cell suspension solution containing 7.5x10
5
 cells per ml in 
serum free DMEM. After put the inserts into wells containing 500μl of DMEM 
supplemented with 10% FBS, 300μl cell suspension solution were added to the inside of 
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each insert (8μm pore size). Then the cells were incubated for 20 hrs at 37oC and 5% 
CO2 in a humidified incubator.  
After incubation, wet cotton swabs were used to carefully removed non-migration cells 
by swabbing the interior of the inserts. Following that, migratory cells were stained by 
400μl Cell Stain Solution and incubated for 10 mins at room temperature. And then, 
migratory cells were photographed in 4x and 10x objective by using Nikon Digital 
Sight-L2 after being washed several times with water and air dried. To quantify the 
migration cells, 200μl of Extraction Solution were added into each well and incubated 
for 10 mins on an orbital shaker. Finally, 100μl sample was transferred to 96 well 
culture plates and the absorbance at 560 nm was measured by Genios multiplate reader.  
 
2.7 Cell Apoptosis 
To evaluate the change of the density of apoptotic BMSCs before and after ERp29 
knockdown, the DeadEnd
TM
 Fluorometric TUNEL System (Promega, U.S.A.) was used 
on rat BMSCs grown on coverslips in 24 well culture plates. After washed 3 times in 1x 
PBS, cells on coverslips were fixed in 4% menthanol-free formaldehyde solution in 1x 
PBS for 25 mins in 4
o
C, And then the cells were washed 2 times in 1x PBS, followed by 
permeablilized with 0.2% Triton X-100 for 5 mins and washed 2 times in 1xPBS in 
room temperature. Subsequently, each coverslip was covered by 100μl of Equilibration 
Buffer for 10 mins at room temperature before incubated with100μl rTdT buffer 
containing 90μl Equilibration Buffer, 10μl Nucleotide Mix and 2μl rTdT Enzyme at 
37
o
C for 1hr in a humidified chamber, and protected from light. The reaction was 
stopped by immersing the coverslips in 2x SSC Buffer for 15 mins at room temperature 
in the dark. Before staining the nucleus with DAPI (Sigma) for 3 mins at a 
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concentration of 1:4000, the coverslips were washed 3 times with deionized water to 
remove unincorporated fluorescein-12-dUTP. Lastly, the cells were washed again 3 
times in 1xPBS and then mounted on glass slides with fluorescent mounting medium 
(Dako, Denmark). Green (apoptotic cell nucleus) and blue (DAPI stained cell nucleus) 
fluorescent signals were captured with the OLYMPUS confocal laser canning 
microscope. The density of apoptotic cells was stated as an average of five randomly 
chosen fields. 
 
2.8 Immunofluorescence and Confocal Microscopy 
Immunofluorescence analysis was carried out on rat BMSC samples before and after 
ERp29 knockdown. The BMSCs were stained for ERp29 at a concentration of 1:500, 
PAR3 and PAR6 at a concentration of 1:100. Goat anti-rabbit Secondary antibody 
conjugated to CY3 (Sana Cruz) was used at a concentration of 1:200. To begin with, 
BMSCs plated on coverlips in 24 well culture plates were washed 3 times in 1x PBS for 
5 mins each, before fixed with 4% formaldehyde in 1x PBS for 25 mins at room 
temperature. And then the cells were washed 3 times in 1x PBS for 5 mins each. Cells 
were permeabilized with 0.1% Triton X-100 for 10 mins at room temperature before 
another 3 times of 1x PBS wash. Following that the cells were blocked in 5% goat 
serum for 1 hrs at room temperature. The cells were then incubated overnight with 
primary antibodies diluted by 3% Bovine serum albumin (BSA) (Bio-Rad) in 0.1% 




The next day, the cells were washed 3 times with 1x PBS for 10 mins each before 
secondary antibody diluted by 3% BSA in 0.1% PBST was added and incubated for 1 hr 
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in room temperature. After washed 3 times in 1x PBS for 5 mins each, DAPI was added 
and incubated for 3 mins at a concentration of 1:4000 at room temperature. Finally, the 
cells were washed 3 times in 1x PBS for 5 mins each and then mounted on glass slides 
with fluorescent mounting medium (Dako, Denmark). Red (ERp29, PAR3 or PAR6) 
and blue (DAPI) fluorescent signals were captured with the OLYMPUS confocal laser 
canning microscope.  
 
2.9 Immuno-blot analysis 
2.9.1 Protein Extraction and Protein Denature 
Proteins extracted from rat BMSCs before and after ERp29 knockdown were applied to 
Western Blot Analysis. Firstly, the cells were washed 2 times with 1x PBS. Then the 
cells were lysed by added lysis buffer, which consisted by M-PER Mammalian Protein 
Extraction Reagent (Pierce), EDTA and Protease Inhibitor (Halt Protease Inhibitor 
Cocktail, Pierce) at a concentration of 1:100, and gently shook for 5 mins. Following 
that the cells were scraped off the base with the help of cell scrapers. Subsequently, the 
lysate were collected and transferred into 2ml Eppendorf tubes, and spun at 14x10
3
 rpm 
for 10 mins at 4
o
C.  Finally, the supernatant was collected and transferred to new 
Eppendorf tubs.Supernatant was aliquoted into small vials. 1 vial of 30μl of supernatant 
was set aside for protein concentration analysis. Every 5 volume of left supernatant was 
mixed with 1 volume of 6x loading dye and then heated on the heat block to 95
o
C for 5 







2.9.2 Protein Concentration Analysis 
To calculate the protein concentration, a protein standard was firstly prepared by mixing 
50μl of BSA with 25μl of purified water to reach a final concentration of 1.2 mg/ml. 
Then the BSA solution was subsequently diluted to concentrations of 0.6, 0.3, 0.15, and 
0.075 mg/ml. To acquire the protein standard, 10μl of each dilution was added into 
200μl of Protein Assay (Bio-Rad). As for the protein samples to be tested, 10μl of each 
sample was added to 50μl of purified water to acquire a 6x dilution. Subsequently, 10μl 
of each dilution was added to 200μl of Protein Assay. Following that, the optical density 
(OD) was read at 595nm by the Genios multiplate reader. Finally, a graph of protein 
concentration against OD value was plotted, and according to this graph, concentrations 
of test protein were calculated. 
 
2.9.3 Western Blot 
To begin with, 10% SDS polyacrylamide separating gels were prepared to separate the 
protein samples. Then 10μg or 20μg of total protein for each sample were added in 
different lanes. To identify the size of separated proteins, the Precision Plus Protein 
Dual Color Standard (Bio-Rad) was used as a marker. Subsequently, the gels with 
protein samples were put in the Mini Protean 2D-gel Electrophoresis tank (Bio-Rad) 
and ran for 2 hrs at 100V. Following that, the completed gels were electro-transferred 
onto polyvinylidene difluoride (PVDF) membranes by using a Semi-dry Transfer Cell 
(Trans-blot SD, Bio-Rad) for 1hr 30 mins at 25V. After transfer, the PDVF membrane 
strips were blocked with 5% nonfat milk in 0.1% TBS-Tween 20 (TBST) on a shaker at 
room temperature for 1hr.  And then the membrane strips were incubated in the primary 





The next day, after first washed with 1x TBST 3 times for 15 mins each, the membrane 
strips were then incubated in horseradish peroxidase-conjugated secondary IgG diluted 
by 5% nonfat milk in 0.1% TBST for 1 hr at room temperature. Subsequently, the 
chemiluminescent substrate (SuperSignal West Dura Extended Duration Substrate; 
Pierce) was added on the membrane strips and incubated in dark for 5 mins before X-
ray film exposure. The level of β-actin was used as the loading control.  
 
Table 2.2 Antibody Dilutions for Western Blot Procedure 




1:2500 Goat anti-rabbit 




1:1000 Goat anti-rabbit 




1:1000 Goat anti-rabbit 




1:5000 Goat anti-mouse 




2.10 Quantitative Real Time Polymerase Reaction 
2.10.1 Total RNA isolation 
To analyze the changes of ERp29, PAR3 and PAR6 RNA expression after ERp29 
knockdown, RNA from rat BMSCs were extracted by using the Rneasy Mini Kit 
(Qiagen). Firstly, cells cultured in 25 cm
2
 culture flasks (Cellstar, U.S.A) or 6 well 
culture plates were washed 2 times with 1x PBS to remove the culture medium. Then a 
mixture of 300μl of RLT buffer which contained 1% β-mercaptoethanol (β-ME) was 
added in the flasks or wells to lyse the cells. Subsequently, the cells were scarped from 
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the flask or plate surface by using cell scrapers and transferred to just autoclaved 2ml 
Eppendorf tubes. Following that, each 2ml tube was applied to homogenization by 
passing the lysate at least 10 times through a blunt 21-gauge needle fitted to an RNase-
free syringe to ensure complete cell lysis. After an equal volume of 70% ethanol was 
mixed well into the lysate, the mixture was the transferred to the MiniElute spin 
columns and centrifuged at 13.2x10
3
 rpm for 30 secs. Flow-through in the collection 
tube was discarded in the waste bin and 700μl of RW1 buffer was added in the spin 
column and centrifuged at 13.2x10
3
 rpm for 30 secs to wash the spin column membrane. 
And then, DNase I was added and incubated in the sample for 15 mins at room 
temperature for each column to remove the trace of genomic DNA after discarded the 
flow-through.  For a complete washing, another 700μl RW1 buffer, 500μl RPE buffer, 
and another 500μl RPE buffer were added subsequently to each column followed by 
centrifuging at 13.2x10
3
 rpm for 30 secs, 2 mins, and 1mins each and discarding the 
flow-through. Lastly, after placed each spin column in a new 1.5ml collection tube, 30μl 
of RNase-free water was applied directly to the spin column membrane to dissolve the 
accumulated RNA. After a final centrifugation at 13.22x10
3
 rpm for 1 min, the extracted 
RNA was stored at -80
o
C for future use. 
 
2.10.2 First strand cDNA synthesis 
The concentrated of purified RNA from above step was first tested by using the 
Nanodrop machine. And then, the isolated RNA was converted to cDNA by using the 
Hybaid PCR machine. Firstly, a total volume of 15μl of RNA mixture was obtained by 
mixing 2μg volume of RNA, 2μl of Oligo dT primers (Promega), and DEPC treated 
purified water together. Following that, this mixture was placed in a pre-heated PCR 
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machine for 5 mins at 70
o
C. And then, the thin based tubes were taken out and placed in 
ice immediately to decrease the temperature of the tubes for further addition of 
subsequent enzymes. After 5 mins, a mixture consisted by 5μl of PCR buffer (Promega), 
1.25μl of dNTP (Promega), 0.675μl of RNase inhibitor (Promega) and 1μl of M-MLV 
reverse transcriptase (Promega) was added into each tube and topped up to a total 
volume of 25μl with DEPC treated purified water. Subsequently, the synthesis was 
continued and programmed to run for 1 hr at 42
o
C and 5 mins at 90
o
C in the PCR 





2.10.3 Real Time Polymerase Chain Reaction 
The first strand cDNA synthesized in the earlier step were used as templates to run the 
real time Polymerase Chain Reaction (RT-PCR). Primers needed in the RT-PCR were 
first designed by using Primer3 Input System and then the sequences of primers 
acquired from the system were blast against the National Center for Biotechnology 
Information Database. Subsequently, the obtained primers (1
st
 BASE) were diluted to 
2nm/μl with purified water.  
 
To start with the RT-PCR, Master Mix was prepared by loading 3μl of RNase-free PCR 
buffer (Qiagen), 5μl of SYBR green mastermix (Qiagen), 0.5μl of forward primer, 0.5μl 
of reverse primer and 1μl of diluted cDNA into 20μl capillaries. Then the mixture in 
each capillary was placed in and amplified with the LightCyler 2.0 Instrument (Roche). 
GAPDH was used as the loading control.  After the amplification, the fold changes were 
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calculated with the cross point (CT) values acquired from the software by using the 
following formula:  
Fold change = 2^ [(cross point of control gene - cross point of control GAPDH) - (cross 
point of treated gene - cross point of treated GAPDH)] 
Table 2.3 Primers for quantitative RT-PCR 
Gene 
Symbol 















2.11 Agarose Gel Electrophoresis 
To study the effect of RT-PCR more directly, RT-PCR amplified products were 
analyzed on 1.5% agarose gels. To prepare the agarose gels, 1.5g of agarose power was 
added into 100ml of 1xTAE buffer (1
st
 BASE), and then the mixture was heated in a 
microwave oven until the agarose power was completely dissolved. Following that, 5μl 
of ethidium bromide was added into the mixture when the temperature was slightly 
dropped off. Subsequently, the mixture was poured into the tray and awaited until it was 
totally solidified.  
 
After the gel had totally solidified, the PCR contents obtained from the above step were 
then centrifuged out of the capillaries into 1.5ml Eppendorf tubes. Following that, 2μl of 
6x DNA loading dye (Promega) was added into each tube and thoroughly mixed with 
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the 10μl PCR contents. Subsequently, 10μl of each sample were loaded into the wells 
on the solidified gels and ran for 1hr at 80V in 1xTAE buffer. Visualization of the 
amplicons was carried out by using the Chemi Genius Bio Imaging System (SynGENE, 
UK) and images of the outcome were captured by the GeneSnap Software (SynGENE, 
UK). 
 
2.12 Statistical Analysis  
All cell culture experiments were performed in triplicate and repeated at least twice. 
One-way analysis of variance or the student’s T-Test was carried out. Two-tailed P-
value of less than or equal to 0.05 was considered as significant. The mean standard 


























3.1 Morphology Characteristics of BMSCs  
 
Figure A&B 3.1 Morphology of BMSCs. The BMSCs present small cell bodies, 
which are long and thin, while some cell bodies spread out and appear more flatten. The 
cell body contains a large and round nucleus, which has a clear appearance. (A) 
Morphology of BMSCs before ERp29 knockdown. Black arrow indicated a 
heterogeneous cell. Bar = 50μm. (B) Morphology of BMSCs after ERp29 knockdown. 
Black arrow indicated a heterogeneous cell. Bar = 50μm. 
 
Twenty-four hours after seeding, the cells were broadly dispersed and therefore 
demonstrated the typical fibroblast like morphology as shown in Figure 3.1 (A): a 
small cell body with a few cell processes that are long and thin. The cell body contained 
a large and round nucleus which had a clear appearance because of the presence of the 
prominent nucleolus enveloped by finely dispersed chromatin particles. The long and 
thin cell bodies would widely spread out and form the adjacent extracellular matrix.  
This picture was taken at passage 4, so some heterogeneous cells (black arrow), which 
might be undergoing differentiation, could be observed. Figure 3.1 (B) showed the 
morphology of BMSCs after ERp29 silencing. Most of the cells still maintained the 
typical fibroblast like morphology. Some heterogeneous cells indicated by black arrow 
could be observed.  
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Figure3.2 A, B, C, D& E Successful Knockdown of ERp29 in BMSCs. ERp29+ 
represents BMSCs without transfection, control represents BMSCs transfected with 
scrambled control siRNA and ERp29- represents BMSCs transfected with scrambled 
ERp29 siRNA. (A) DNA gel electrophoresis after RT-PCR amplification. GAPDH was 
used as loading control. The expression of ERp29 mRNA level notably decreases after 
ERp29 transfection in comparison to that of the negative control. (B) Graph 
demonstrating the average decreases in ERp29 expression at mRNA level after ERp29 
silencing, which reveal 12.6-fold of decrease compared to the negative control. Bar 
graphs represent mean ± SD from three independent experiments. **p<0.01. (C) 
Western blot. β-actin was used as loading control. Expression of ERp29 protein level 
also considerably reduces after ERp29 silencing compared to the control. (D) Graph 
demonstrating the average decreases in ERp29 expression after ERp29 silencing, which 
revealed 6.3-fold of decrease compared to the negative control. Bar graphs represent 
mean ± SD from three independent experiments. **p<0.01. (E) Immunofluorescence. 
Red Cy3 stained for ERp29 and DAPI-blue staining was used to visualize DNA (40x 
magnification). ERp29 is localized to endoplasmic reticulum of BMSCs. ERp29 
fluorescent markedly decreased after ERp29 silencing compared to the negative control. 




Gene transfection is a common used powerful method to unravel protein functions. 
Therefore, to clarify the role of ERp29 in mediating the basic activities of BMSCs, the 
cells were transient-transfected with ERp29 siRNA after the confirmation of ERp29 
presence in BMSCs, which had been identified at mRNA and protein level by using RT-
PCR, Western blot, as well as immunofluorescence assays (Figure 3.2 A, B, C, D and 
E). The effectiveness of ERp29 silencing was also verified by these three methods (also 
shown in Figure 3.2 A, B, C, D and E). After transfection, the expression of ERp29 in 
BMSCs was dramatically reduced. Using GAPDH as the loading control, expressions of 
ERp29 mRNAs revealed 12.6-fold of decrease compared to the negative control (Figure 
3.2 A&B). And the expressions of ERp29 proteins revealed 6.3-fold of decrease 
compared to the negative control while β-actin was used as loading control (Figure3.2 
C&D). Observations from immunofluorescence assay also suggested the expression of 
ERp29 significantly reduced compared to the negative control and BMSCs before 
knockdown, which is consistent with those observed from western blot (Figure 3.2 E). 
The mRNA used for RT-PCR was isolated 48 hrs after ERp29 siRNA transfection, 
while the protein used for western blot was extracted after 72 hrs after ERp29 silencing. 





3.3 Knockdown of ERp29 in BMSCs Reduced the Ability of Migration  







Figure 3.3 A, B, C&D Knockdown of ERp29 in BMSCs Reduced the Ability of 
Migration. ERp29+ BMSCs represents BMSCs without transfection, negative control 
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represents BMSCs transfected with scrambled control siRNA and ERp29- BMSCs 
represents BMSCs transfected with scrambled ERp29 siRNA. (A) Migration ability of 
BMSCs was evaluated before and after ERp29 silencing by wound healing assay (10x 
magnification). Monolayer cells were wounded and photographs were taken 
immediately after wound induction, 12 hrs and 15 hrs (or 15 hrs and 18 hrs for BMSCs 
after ERp29 knockdown) later. The migration ability of BMSCs is remarkably 
decreased after ERp29 knockdown compared to the negative control and the BMSCs 
before knockdown. (B) To quantify the migration cells, the number of migration cells 
was calculated 15hrs after wound induction. Migratory BMSCs were remarkably 
decreased, which demonstrated 1.85-fold of decrease, after ERp29 knockdown 
compared to the negative control. Bar graphs represent mean ± SD from three 
independent experiments. **p<0.01. (C) Migration ability of BMSCs was evaluated 
before and after ERp29 silencing by transwell migration assay (4x /10x magnification). 
After removing non-migration cells, migratory cells at the bottom of the membrane 
were stained by Cell Stain Solution and photographed 20 hrs after being seeded. 
Migratory BMSCs, which are stained as dark blue, are remarkably less in numbers after 
ERp29 silencing compared to the negative control. Bar = 50μm. (D) To quantify the 
migration cells, Extraction Solution were added and then the absorbance at 560 nm was 
measured. Knockdown of ERp29 in BMSCs notably decreased the cell motility. The 
absorbance revealed 1.83-fold of decrease compared to the negative control. Bar graphs 
represent mean ± SD from three independent experiments. **p<0.01. 
 
Wound healing assay and tranwell assay were applied to elucidate the migration 
properties of BMSCs after ERp29 silencing. Both methods demonstrated that the 
migration ability of BMSCs was remarkably decreased after ERp29 knockdown 
compared to the negative control and the BMSCs before knockdown (Figure 3.3 A, B, 
C& D). The wound healing ability of ERp29-silencing BMSCs were remarkably 
repressed in comparison to that of negative control. It took 18hrs for the ERp29-
silencing BMSCs to cover half of the wound, while the negative control only needed 12 
hrs (Figure3.3 A).  The quantitative analysis by calculating the number of migratory 
cells demonstrated 1.85-fold of reduction of migratory cells after ERp29 silencing 
compared to the negative control (Figure3.3 B). In the transwell migration assay, the 
number of migratory cells at the bottom of chamber membrane was largely reduced 
after ERp29 silencing, which was consistent with the observation in wound healing 
assay. After knockdown of ERp29, the number of migratory cells stained as dark blue 
decreased almost half compared to the negative control and BMSCs before silencing 
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(Figure3.3 C). The quantitative analysis using the transwell chamber further showed the 
reduction of cell migration ability after ERp29 silencing. Absorbance of OD560 
revealed 1.8-fold of decrease compared to the negative control (Figure3.3 D). 
 











Figure 3.4 A, B, C, D, E& F Knockdown of ERp29 Decreased the Expression Level 
of Par3 and Par6. ERp29+ BMSCs represents BMSCs without transfection, negative 
control represents BMSCs transfected with scrambled control siRNA and ERp29- 
BMSCs represents BMSCs transfected with scrambled ERp29 siRNA. (A) DNA gel 
electrophoresis after RT-PCR amplification. Par3 and Par6 expression in BMSCs was 
examined at mRNA level before and after silencing of ERp29. GAPDH was used as 
loading control. The expressions of Par3 and Par6 mRNA levels notably decrease after 
ERp29 transfection compared to negative control. (B) Graph demonstrating the average 
decreases in Par3 and Par6 expressions at mRNA level after ERp29 silencing, which 
reveal 5.7- and 5.4-fold of decrease compared to the negative control respectively. Bar 
graphs represent mean ± SD from three independent experiments. **p<0.01. (C) 
Western blot. Par3 and Par6 expression in BMSCs was examined at protein level before 
and after silencing of ERp29. β-actin was used as loading control. Expression levels of 
Par3 and Par6 proteins also considerably reduce after ERp29 silencing compared to the 
control. (D) Graph demonstrating the average decreases in Par3 and Par6 expression at 
protein level after ERp29 silencing, which reveal 3.7- and 5.4-fold of decrease 
compared to the negative control respectively. Bar graphs represent mean ± SD from 
three independent experiments. **p<0.01. (E) Immunofluorescence. Red Cy3 stained 
for Par3 and DAPI-blue staining was used to visualize DNA (40x magnification). Par3 
fluorescence highly decreases after ERp29 silencing compared to the negative control. 
Bar = 50μm. (F) Immunofluorescence. Red Cy3 stained for Par6 and DAPI-blue 
staining was used to visualize DNA (40x magnification). Par6 fluorescence markedly 
decreases after ERp29 silencing compared to the negative control. Bar = 50μm. 
 
Par3 and Par6, the member of Par polarity complex, are playing an essential role in the 
initial step of polarization, which then initiate the migration cycle. To further study the 
possible role of ERp29 in regulating cell migration in BMSCs, expression level of Par3 
and Par6 was tested at mRNA and protein level by using RT-PCR, Western blot, as well 
as immunofluorescence assays (Figure 3.4 A, B, C, D, E and F). After ERp29 silencing, 
the expression of Par3 and Par6 in BMSCs was largely decreased. Using GAPDH as the 
loading control, expressions of Par3 and Par6 mRNAs revealed 5.7- and 5.4-fold of 
decrease respectively compared to the negative control (Figure 3.4 A&B). And the 
expressions of Par3 and Par6 proteins revealed 3.7- and 5.4-fold of decrease compared 
to the negative control respectively while β-actin was used as loading control (Figure3.4 
C&D). Observations from immunofluorescence assay also suggested the expression of 
Par3 andPar6 was significantly reduced compared to the negative control and BMSCs 
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before knockdown, which is consistent with those observed from western blot (Figure 
3.4 E&F). The mRNA used for RT-PCR was isolated 48 hrs after ERp29 siRNA 
transfection, while the protein used for western blot was extracted after 72 hrs after 
ERp29 silencing. 
 
3.4 Knockdown of ERp29 Increased Apoptosis of BMSC 
 
Figure 3.5 A Knockdown of ERp29 in BMSCs Increased the Cell Apoptosis. (A) 
Cell apoptosis in BMSCs was measured by TUNEL assay. After been fixed on 
coverslips, cells were incubated with rTdT buffer containing fluorescein-12-dUTP, 
which incorporated with the fragmented DNA of apoptotic cells. The number of 
fluorescein-12-dUTP labeled nuclear DNA fragments is largely increased after ERp29 
knockdown compared to the negative control. Green fluorescein-12-dUTP stained for 
DNA fragments of apoptotic cells and DAPI-blue staining was used to visualize DNA 
(10x magnification). The number of fluorescein-12-dUTP staining markedly increases 





Figure 3.5 B Knockdown of ERp29 in BMSCs Increased the Cell Apoptosis. (B) 
The density of apoptotic cells was calculated based on the TUNEL assay. The 
percentage of apoptotic cells was stated as an average of five randomly chosen fields. 
The percentage of apoptotic cells is remarkably increased after ERp29 silencing 
compared to the negative control. Bar graphs represent mean ± SD from three 
independent experiments. **p<0.01 
 
To investigate the possible role of ERp29 in mediating cell apoptosis, TUNEL assay 
was carried out in BMSCs before and after ERp29 silencing. After knockdown, the 
apoptotic cells whose nuclear DNA fragmentations were stained as green were 
dramatically increased in numbers compared to the negative control (Figure 3.5 A). 
Furthermore the percentage of apoptotic cells calculated based on the TUNEL assay 
confirmed the observation, which showed that the percentage of apoptotic cells in 





3.5 Knockdown of ERp29 Inhibited Proliferation of BMSCs  
 
 
Figure 3.6 Knockdown of ERp29 in BMSCs Inhibited Cell Proliferation. The 
relative growth rate of BMSCs was tested by proliferation assay. After been seeded in 
96 well culture plates, the absorbance of OD490 was measured each 24 hrs interval. The 
relative growth rate was conducted by OD490n/OD4901 (n=1, 2, 3, 4). OD4901 
represents the OD490 value measured 1 day (24hrs) after seeding. And OD490n 
represents the OD490 value measured n days (n×24hrs) after seeding. After ERp29 
knockdown, the relative growth rate slightly decreased, especially 48hrs and 72hrs after 
been seeded compared to control. However the deduction was not statistically 
significant. Blue line represents BMSCs before ERp29 silencing, while red line and 
green line represent negative control, and BMSCs after ERp29 silencing respectively. 
Bar graphs represent mean ± SD from three independent experiments. 
 
The definition of cell proliferation is an increase in the number of cells as a result of cell 
growth and cell division, which is essential for cells to maintain their reproduction and 
basic function. To characterize the possible association of ERp29 with cell proliferation 
in BMSCs, the proliferation assay over a 96-hr period was conducted before and after 
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is observed in ERp29-silencing BMSCs compared to the negative control, especially 
48hrs and 72hrs after been the cells being seeded. However, this inhibition is without 















4. Discussion  
Recent studies have established the important role of ERp29 in mediating secretory 
proteins in secretory tissues, regulating cell proliferation and MET (Mesenchymal-
Epithelial Transition) in breast cancers cells, and involving in the ER-based 
neuropathophysiology neuronal cells in the brain (Baryshev et al., 2006; Das et al., 
2009; Mkrtchian and Sandalova, 2006; Bambang et al., 2009b; MacLeod et al., 2004). 
However, it is still unclear how ERp29 function in BMSCs. In this present study, 
BMSCs were transient-transfected with ERp29 siRNA. Knockdown of ERp29 resulted 
in down-regulated cell migration, up-regulated cell apoptosis, and possibly cell 
proliferation in BMSCs. 
 
In this chapter, discussions will be focused on: (1) plausible explanations for these 
findings, (2) possible mechanisms that mediate ERp29-induced changes of cell 
migration, apoptosis and proliferation, (3) the clinical significance of this study in 
unraveling the functions of ERp29 in BMSCs. 
 
4.1 Down-regulated Cell Migration Induced by Knockdown of ERp29 
Cell migration is an extremely integrated multi-step process. It is not only playing an 
important role in implicating in embryonic morphogenesis, tissue repair and 
regeneration, but also essential to disease progression such as cancer, mental retardation, 
and atherosclerosis. Migration behavior in mammalian cells has two common features: 
the behavior of the leading front and the observation that any debris on the dorsal 
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surface of the cell moves backward on the cell’s surface toward its trailing end 
(Abercrombie et al., 1970).  
In this study, knockdown of ERp29 resulted in down-regulated cell migration and 
down-regulated expression of Par3 and Par6 in BMSCs, which indicates that ERp29 
may be involved in the Par6-Cdc42 pathway, which might activate Par3 and then 
regulate the cell migration in BMSCs. ERp29 may also cooperate with other migration 
regulators and therefore regulate cell migration through other pathways, such as Cdc42- 
PAK1 pathway and/or Cdc42-PI3K-Rac pathway.  
 
In the migration cycle, the initial step is polarization and formation of protrusions and 
adhesion in the direction of migration, and then followed by rear retraction. This 
multiple-step process is mediated by various regulators and pathways. Among them, the 
par polarity complex, consisting of Par3, Par6 and aPKC, is playing an important role in 
the initial step of polarization. The Par polarity complex was first identified in 
Caenorhabditis elegans in 1998 (Kemphues et al., 1988). The Par complex has been 
proved to be involved in most types of cell polarity. Among these polarity systems, 
apical–basal polarity in Drosophila is the best understood polarity system regulated by 
the Par complex. To establish the apical–basal polarity in Drosophila epithelium, Par3, 
Par6 and aPKC have to be firstly recruited to the lateral cell membrane. Any mutation 
or loss of the Par complex protein will lead to deficiency of establishment of apical 
identity (Humbert et al., 2006). Par3 is responsible to assemble the Par complex at the 
apical-lateral border by binding to Par6 and recruiting Par6-associated proteins (Aranda 
et al., 2008). Par6 is a scaffolding protein that can bind directly to Par3, the regulatory 
domain of aPKC and Cdc42/Rac. In Drosophila epithelium, GTP-bound Cdc42 binds to 
Par6, therefore activates the recruitment of the Par complex to the cell cortex. The 
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spatio-temporal activity of aPKC is also be inhibited by this interaction. Moreover, 
aPKC has been proven to physically bind to and phosphorylate both the transmembrane 
protein Crb and Lgl, therefore functionally interacting with the Crumbs, Scribble and 
Par polarity complexes (Humbert et al., 2006). 
 
Another important role of the Par complex is regulating the process of directed 
migration by implicating in the initial polarization events. In this model, engagement of 
integrins with the extracellular matrix at the newly formed cell front results in the 
activation and polarized recruitment of Cdc42, which then subsequently recruits and 
activates a cytoplasmic Par6–aPKC complex (Humbert et al., 2006). The Par6-aPKC 
complex plays an essential role in coordinating the stepwise events of polarized 
movement. The spatially restricted aPKC leads to the interaction of the adenomatous 
polyposis coli (APC) tumor suppressor protein, which then binds to the plus end of 
microtubule at the leading edge, therefore subsequently regulate polarization of the 
microtubule cytoskeleton (Humbert et al., 2006). Additionally, the Par6–aPKC complex 
at the leading edge locally recruits E3 ubiquitin ligase Smurf1 to active sites of 
membrane protrusion, and then to target RhoA for degradation, thus to restrict Rho 
activities (Aranda et al., 2008).  
 
Besides of the Par polarity complex, several other regulators are also essential in the 
process of polarization. Of which, Cdc42 is the major regulator (Ridley et al., 2003). 
Cdc42 regulated the direction of migration by three aspects: (1) Cdc42 is activated at 
the front of migrating cells; (2) Cdc42 restricts lamellipodia formation; (3) Cdc42 
regulates the orientation of MTOC and Golgi apparatus, which is in front of the nucleus, 
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oriented toward the leading edge (Etienne-Manneville and Hall, 2002; Itoh et al., 2002; 
Srinivasan et al., 2003; Ridley et al., 2003). Cdc42-induced MTOC orientation, which is 
regulated  by Par6, may facilitate the formation of lamella and the delivery of Golgi-
derived vesicles to the leading edge by mediating microtubules, therefore assists the 
formation of protrusion by providing the required membrane and associated proteins in 
the migration process of slow-moving cells (Etienne-Manneville and Hall, 2002; 
Rodriguez et al., 2003). PAK1 is one of downstream targets of Cdc42. It can activate 
heterotrimeric GTP-binding protein (G protein)–coupled receptors through the positive 
feedback loop between Cdc42 and PAK1, which also lead to high Cdc42 activity at the 
front of migrating cell (Li et al., 2003). The localized activation and accumulation of 
PI3Ks in the leading edge result in generation of the phosphatase PTEN and 
amplification of small difference in signaling between front and rear, and therefore 
generating a cellular response (Ridley et al., 2003).  
 
The formation of protrusion is initiated and maintained by the localized Rac activation, 
which is a downstream target of Cdc42 and PI3K.  Once Rac is active, microtubules and 
Rac may form a positive feedback loop in which microtubule polymerization activates 
Rac, and Rac in turn stabilizes microtubules (Rodriguez et al., 2003). Meanwhile, 
integrin engagement results in Rac activation, which in turn induces recruitment and 
clusterin of activated integrins to the edge of lamellipodia (Kiosses et al., 2001; 
Schwartz and Shattil, 2000). Rac also contributes to stimulate the recruitment and/or 
activation of PI3Ks at the plasma membrane and to form the positive feedback loop 




Rho had dual character in the migrating cell rear. In some cells, the formation of an 
extended cell rear is triggered by inhibition of Rho. In some cells, Rho in the tail may 
act as stabilizing microtubules, which would then promote focal adhesion (Small and 
Kaverina, 2003; Rodriguez et al., 2003). In the front of the migrating cell, activated Rac 
would restrain Rho activity, whereas Rho would be more activated at the sides and back 
of the cell and therefore restrain Rac activity (Worthylake and Burridge, 2003; Xu et al., 
2003).  
 
Earlier studies has revealed that knockdown of ERp29 may negatively regulate cell 
migration in MDA-MB-231 breast cancer cells, while positively regulate cell migration 
in MCF-7 breast cancer cells (Bambang et al., 2009b). This regulation may be 
conducted through the ERp29 induced MET (Bambang et al., 2009b). In ERp29-
induced MET, ERp29 has demonstrated its ability in mediating the expression of Par3 
and Scribble in MDA-MB-231 and MCF-7 breast cancer cells (Bambang et al., 2013). 
In addition, in the RT-PCR array-based gene expression profiling, PI3K gene was 
increased by ERp29 in ERp29-transfected MDA-MB-231 breast cancer cells (Bambang 
et al., 2009b).  
 
In concert with the above findings, the present study suggests that the down-regulation 
in cell migration might be mediated by the following possible mechanisms. Firstly, the 
knockdown of ERp29 independently down-regulated the expression of Par6, which 
might further down-regulate the recruitment of Par3, the activation of PAK1 and the 
orientation of MTOC and Golgi apparatus through the Par6-Cdc42 pathway. Secondly, 
ERp29 might also independently down-regulate the expression of Par3 and finally result 
in a decrease in cell migration. Thirdly, the activation of PI3K was also decreased 
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because of knockdown of ERp29, which might therefore lead to a down-regulation in 
the localized activation of Rac and then declined cell migration. Lastly, the knockdown 
of ERp29 might also down-regulate the expression of Scribble and then consequently 
down-regulate the cell migration. 
 
4.2 Apoptosis Induced by Knockdown of ERp29 
The principle of apoptosis was first recognized as a nature process to remove unwanted 
cell debris during embryonic development (Saunders, 1966). Apoptosis is a multi-
process of self-destruct, which is activated by an intrinsic cellular suicide program. 
Apoptotic cells often break into membrane-bound apoptotic bodies, which are then 
rapidly phagocytosed and digested by macrophages without generating any 
inflammatory responses. The DNA in apoptotic cells is fragmented into multimers of 
oligonucleosomal size (180–200bp) fragments. In many cell types, nuclear DNA 
fragmentation is one of the essential biochemical features of apoptosis in eukaryotic 
cells. Apoptosis is vital in developing and maintaining the homeostasis. And it is also 
plays an important role in the maturation of nervous and immune systems. Moreover, it 
is a central part of self-defense mechanism by removing unwanted and potentially 
dangerous cells including self reactive lymphocytes, virus infected cells and tumor cells 
(Estaquier et al., 2012).  
 
The deficiency of ERp29, a vital ER stress protection protein, can exacerbate ER stress, 
and then trigger programmed cell death, mainly through apoptosis (Qi et al., 2012). In 
this study, increased cell apoptosis, induced by knockdown of ERp29, has been 
observed in BMSCs, which is consistent with findings that silencing of ERp29 
increased the radiation-induced apoptosis in CNE-1 cells and doxorubicin induced 
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breast cancer cells(Qi et al., 2012; Zhang and Putti, 2010). Studies have demonstrated 
that ER stress has the ability to trigger the activation of caspase-8 and stimulating the 
release of cytochrome c, therefore activate caspase-9 (Momoi, 2004; Jimbo et al., 2003; 
Banjerdpongchai et al., 2010). It is also reported that ERp29 mediates cell apoptosis 
through heat shock protein 27 (Hsp27) in breast cancer cells. These could suggest that 
ERp29 might induce cell apoptosis through caspase-8/9 pathway and/ or Hsp27 
pathway. 
 
ER is a site of regulation for cell death (Ferri and Kroemer, 2001). Depending on the 
ER-associated degradation system (ERAD), a large amount of malfolded and unfolded 
proteins are translocated from the ER to the cytoplasm and then are degraded (Momoi, 
2004). However, apoptosis will be activated by prolonged ER stress through different 
pathways when the degradation is not sufficient (Momoi, 2004).  
 
ER stress stimuli, such as thapsigargin and tunicamycin, induce the activation of 
caspase-12 via m-calpain, another cysteine protease (Nakagawa and Yuan, 2000; 
Momoi, 2004). Consequently, calcium is released from the ER and then directly induces 
apoptosis without the association with other apoptotic caspases (Jimbo et al., 2003).  
This process could be mediated by GRP78 and TNF receptor-associated factor 2 
(TRAF2). GRP78, the ER chaperone protein, protects cell from apoptosis induced by 
ER stress by forming a complex with caspase-12 and preventing the release of caspase-
12 from the ER (Rao et al., 2002; Reddy et al., 2003). TRAF2, the cytosolic adaptor 
protein, is another molecule which complexes with caspase-12. Under ER stress 
caspase-12 is released from TRAF2 complexes and subsequently autoprocessed via 
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homodimerization (Yoneda et al., 2001). TRAF-2 is also essential for the JNK pathway 
in the apoptosis induced by ER stress. Therefore, TRAF-2 is a missing link in the ER 
stress-induced apoptosis signaling pathway, connecting with the stress sensor molecule 
IRE1α and caspase-12 (Momoi, 2004). 
 
Under ER stress, IRE1α recruits TRAF2 and then recruits and activates ASK, the 
proximal component of the c-Jun N-terminal kinase (JNK) pathway (Kyriakis et al., 
1994; Urano et al., 2000). JNK activates the phosphorylation of BIM, a BH3 only Bcl-2 
protein, subsequently results in release of BAX-dependent cytochrome c (Lei and Davis, 
2003; Putcha et al., 2003). And finally, caspase-9 is recruited and activated, which then 
leading to apoptosis. Bcl-2/cb5 and RTN-xs are main regulators of the 
ASK/JUK/caspase-9 pathway. Bcl-2/cb5 inhibits ER stress-mediated 
cytochrome c release while RTN-xs, a member of the reticulon (RTN) family, reduces 
the anti-apoptotic activities of Bcl-2 and Bcl-xL and therefore promotes the ER stress-
mediated apoptosis (Hacki et al., 2000; Tagami et al., 2000).  
 
Prolonged ER stress independently initiates the activation of caspase-8 and leads to 
release of cytochrome c and activation of caspase-9 through BID processing (Jimbo et 
al., 2003). BID locates in the cytosolic fraction in an inactive form and becomes cleaved 
and activated by caspase-8 (Jimbo et al., 2003). After activation, the C-terminal of BID 
translocates to the mitochondrial membrane and then initiates the 
cytochrome c release (Li et al., 1998; Luo et al., 1998). Bap31, the polytopic integral 
membrane protein of the ER, is one of substrates for caspase-8 (Momoi, 2004). 
Caspase-8 may be activated via Bap31 under ER stress. Caspase-8 cleavage of Bap31 at 
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the ER may also stimulate Ca
2+
-dependent mitochondrial fission, therefore promote the 
release of cytochrome c from the mitochondria (Momoi, 2004).  
 
Hsp27, a stress inducible heat shock proteins, is one of the most important proteins that 
inhibit cell apoptosis (Samali et al., 2001). Evidences have shown that Hsp27 can 
increase PI3K activity and Akt expressions, decrease GSK3β activation, therefore 
inhibit BAX activation, oligomerization, and translocation to mitochondria (Havasi et 
al., 2008). This consequently inhibits the activation of caspase-3 and release of 
cytochrome c from mitochondria, which prevents cytochrome-c-mediated interaction of 
Apaf-1 with procaspase-9 and results in reduction of apoptosome formation (Paul et al., 
2002; Garrido et al., 1999; Bruey et al., 2000; Havasi et al., 2008). Hsp27 is mediated 
by the translational initiation factor eIF2a, which involved in PERK/p-eIF2a survival 
signaling (Zhang and Putti, 2010). It is been shown that overexpression of ERp29 has 
the ability to reduce the basal level of eIF2a and to up-regulates the expression of Hsp27, 
therefore down-regulates apoptosis in nasopharyngeal carcinoma (NPC) CNE-1 cells 
and doxorubicin induced MDA-MB-231 breast cancer cell(Qi et al., 2012; Zhang and 
Putti, 2010).  
 
The observations described above suggest that an up-regulation in number of apoptotic 
cells induced by knockdown of ERp29 in BMSCs might be mediated by the following 
apoptotic pathways. (1) Caspase-12 might be activated via m-calpain, following by 
release of calcium and apoptosis. (2) After the activation of ASK/JNK, JNK might 
activate the phosphorylation of BIM, consequently result in the release of BAX-
dependent cytochrome c and recruitment and activation of caspase-9, finally lead to 
apoptosis. (3) Caspase-8 might be activated by its interaction with Bap31, leading to the 
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release of cytochrome c and activation of caspase-9 through BID processing. And 
finally result in apoptosis. (4) Hsp27 might be down-regulated via increased basal level 
of eIF2a. Down-regulated Hsp27 might promote the activation of caspase-3 and release 
of cytochrome c from mitochondria via PI3K-Akt-GSK3β-BAX pathway, which might 
increase cytochrome-c-mediated interaction of Apaf-1 with procaspase-9 and finally 
result in caspase-dependent apoptosis. 
 
4.3 Cell Proliferation Inhibition Induced by Knockdown of ERp29  
Cell proliferation refers to produce two cells (daughter cells) from one cell (mother cell). 
This process requires cell growth and cell division. Various cell proliferation disorders 
can happened at cellular level and consequently lead to critical consequences, such as 
cancer, in which a number of cells undergo uncontrolled cell growth and cell division 
beyond the body control capability. 
 
One of the important capacities of stem cells is the unlimited proliferation while 
preserving the potential to differentiate into a wide range of cell types. The current 
study showed that the proliferation rate of BMSCs decreased after ERp29 knockdown, 
which may suggest that ERp29 might play an important role in regulation of cell 
proliferation in BMSCs. The down-regulated cell proliferation may be triggered by ER 
stress-induced G1 cell cycle arrest via the accumulation of p27(Han et al., 2013).`  
 
In the eukaryotes, cell cycle can be divided into two periods: interphase and mitosis (M 
phase). During the interphase, a cell grows and collects nutrients needed for M phase 
and replicates its DNA (Bryant and Francis, 2008). M phase is the division period, 
during which the cell is split into two daughter cells and ends with cellcytokinesis 
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(Bryant and Francis, 2008). The interphase can be further divided into 3 phases: gap1 
(G1 phase), synthesis (S phase) and gap2 (G2 phase). In G1 phase, cell grows up 
without DNA replication. S phase is the period that DNA replication takes place. S 
phase is followed by G2 phase, during which cell continues to grow and protein 
synthesis occurs. Sometimes, nonproliferative cells in multicellular eukaryotes may 
enter the quiescent gap0 (G0 phase) from G1 phase. In this phase, cell keeps 
metabolically active but stops division.  
 
The cell cycle is mediated by two classes of regulatory molecules, cyclins and cyclin-
dependent kinases (CDKs) (Nigg, 1995). CDKs with catalytic subunit are activated by 
bounding to their partner Cyclins which form the regulatory subunits. After activation, 
CDKs regulate their target proteins by phosphorylation to mediate the entry into the 
next phase of the cell cycle (Nigg, 1995). Cyclin D-CDK4 complex phosphorylates the 
retinoblastoma susceptibility protein (Rb), which then forms the E2F/DP1/Rb complex, 
activates E2F and results in transcription of various genes, such as cyclin E  and cyclin 
A (Nigg, 1995).  The cyclin E-CDK2 complex drives the cell enter S phase from G1 
phase (G1/S transition) (Nigg, 1995). Cyclin B-CDK1 complex triggers the G2/M 
transition.  
 
The CDK activities are negatively regulated by two classes of CDK inhibitor proteins 
(CKI): the cip/kip family and the INK4a/ARF family (Han et al., 2013). The cip/kip 
family includes p21, p27 and p57, which induce the G1 cell cycle arrest by binding to 
and inactivating cyclin-CDK complexes (Toyoshima and Hunter, 1994; Naumann et al., 







 triggers G1 cell cycle arrest by binding to CDK4, while p19ARF negatively 
regulates cell cycle by preventing p53 degradation.  
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Under ER stress, G1 cell cycle arrest is triggered by the increase of p27 in melanoma 
cells (Han et al., 2013). The degradation of p27 is regulated by the activity of pirh2 and 
SCF (Skp1-Cullin-F-box protein)-Skp2 (S-phase kinase-associated protein). pirh2, an 
E3 ligase for p27, is shown to mediate the rapid degradation of p27 (Hattori et al., 2007). 
The SCF-Skp2 complex regulates p27 degradation by inhibiting its polyubiquitination 
(Yam et al., 1999; Han et al., 2013). 
 
The observations described above indicate that further investigation of cell cycle and 
interaction between ERp29 and SCF-Skp / pirh27 should be conducted to identify the 
possible regulation role of ERp29 in mediating the cell proliferation in BMSCs.  It is 
possible that ERp29 might induce decreased expression of SCF-Skp and/or pirh27, 
consequently lead to accumulation of p27 and finally result in G1 cell cycle arrest.  
 
4.4 Clinical Significance 
BMSCs can be used as a therapeutic strategy for a variety of diseases, such as GVHD, 
rheumatoid arthritis, pancreatitis and multiple sclerosis autoimmune diseases (Yi and 
Song, 2012).  The migration property of BMSCs allows them to relocate to the distant 
injury site, therefore guides intrinsic repair and improve disease prognosis (Li and Jiang, 
2011). Considering the role of ERp29 in regulating the migration of BMSCs, it helps us 
to better targeting BMSCs towards the injury sites therefore enable a larger number of 
MSCs to participate in the healing process. 
 
Keeping a balanced number of active stem cells is also vital in the BMSCs therapeutic 
process, which is largely depends on the regulations of apoptosis and cell proliferation. 
As shown in present study, ERp29 is a novel apoptosis regulator of BMSCs. Although 
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this regulation was only demonstrated in healthy BMSCs, ERp29 may also be able to 
mediate the apoptosis in wrongly differentiated and unhealthy BMSCs. Therefore 
understanding the mechanism of ERp29-regulated apoptosis may be of great importance 
in BMSCs therapy by eliminating the wrongly differentiated and unhealthy cells via 
mediated apoptosis. 
 
Unlike other cells, the cell cycle of stem cells is characterized by a very short G1 phase 
and a high proportion of cells in S-phase (White and Dalton, 2005). However, during 
stem cell differentiation, their cell cycle structure changes dramatically and incorporates 
a significantly longer G1 phase (Sommer and Rao, 2002). These distinctive cell cycle 
characteristic and regulation mechanisms suggest that the G1 cell cycle regulation might 
be essential during stem cell differentiation. Therefore provide us the probability that 
BMSCs differentiation might be mediated via ERp29-drived G1 cell cycle regulation 
during the stem cell therapy.  
 
In summary, understanding the role of ERp29 in regulating the migration, apoptosis and 
cell cycle might provide a better understanding of BMSCs behavior change during the 
therapeutic process.  BMSCs might have stronger differentiation capability, be easier to 
















5. Conclusion and Future Studies 
5.1 Conclusion 
This study reveals that knockdown of ERp29 resulted in the decreased migration, 
increased apoptosis and decreased cell proliferation in BMSCs. The decreased 
migration might be induced by the proposed mechanisms. (1) down-regulated Par6 
which could further down-regulate Par3, PAK1 and the orientation of MTOC and Golgi 
via Par6-Cdc42 pathway. (2) A decrease in expression of PI3K might lead to a decrease 
in cell migration by down-regulated the localized activation of Rac. (3) Knockdown of 
ERp29 might also down-regulate the expression of Par3 and scribble. The possible 
mechanisms of up-regulated apoptosis are: (1) Activation of Caspase-12 might lead to 
release of calcium and apoptosis; (2) Activation of ASK/JNK might result in 
phosphorylation of BIM, release of BAX-dependent cytochrome c, activation of 
caspase-9, and finally apoptosis. (3) Caspase-8 might be activated via Bap31, which 
might lead to release of cytochrome c and activation of caspase-9 by BID process; (4) 
basal level of eIF2a might be increased, followed by down-regulated Hsp27, which then 
might promote the activation of caspase-3, release of cytochrome c from mitochondria 
and activation of caspase-9 via PI3K-Akt-GSK3β-BAX pathway. Knockdown of ERp29 
might mediate an inhibition in cell proliferation by G1 cell cycle arrest, which could be 
triggered by accumulation of p27 via down-regulated SCF-Skp and/or pirh27.  
 
5.2 Future Studies 
The novel role of ERp29 in regulating the migration, apoptosis and proliferation 
provides a possible unique method to better mediate the behavior in the clinical BMSC 
therapeutic process. However, the novel role of ERp29 and the possible mechanisms 
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discussed above needs to be further validated. To achieve this goal, several steps would 
be carried out:  
i. Test the possible change of polarization of BMSCs via down-regulated Par and 
Par6 induced by ERp29 silencing. 
ii. Investigate the expression change of other molecular, such as Cdc42, PI3K, Rac 
and Scribble, which may also involve in the migration process in ERp29- 
silencing BMSCs. 
iii. Construct ERp29-overexpressing BMSC single clone, and investigate the 
change of cell migration, apoptosis, proliferation and polarization in ERp29-
overexpressing BMSCs. 
iv. Test each possible pathway mediating cell migration, apoptosis and proliferation 
induced by ERp29 in both ERp29-silencing and ERp29-overexpressing BMSCs.  
v. Observe the possible differentiation change in both ERp29-silencing and 
ERp29-overexpressing BMSCs as differentiation is an essential characteristic of 
BMSCs, such as the differentiated cell types and differentiation rate. 
vi. If ERp29 demonstrates the ability to regulate differentiation of BMSCs, study 
the possible mechanism mediating the differentiation change in both ERp29-
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